Forum pracy nad projektem wskrzeszenia The Forge

[yoylqnqvwb]

Increase the amount of drugs, distribution pattern is still the first half of 2007 of the National Hospital medicine


Big profits and can be used as alternative medicines and other reasons, dosage have shown significant growth. Such as cefoperazone / tazobactam, ranked 242 in the first half of 2006, ranked first half of 2007 51; Paila Xi sulbactam first half of 2006 ranked 189, ranking the first half of 2007 78 ; Oxiracetam first half of 2006 ranked 221 (ranked 183 in 2006),[link widoczny dla zalogowanych], ranked first half of 2007 80; cephalosporin Bangladesh ranked first half of 2006 more than 153 (ranked 108 in 2006) first half of 2007 ranked 52; gefitinib ranked first half of 2006 109 (ranked 100 in 2006), ranked first half of 2007 49. The drugs affected by national policies, the order was back, for example, FDP ranked first half of 2006 45 (ranked 54 in 2006), ranked first half of 2007 93; ceftazidime first half of 2006 ranked 27 (in 2006 ranked 31), ranked first half of 2007 59; clindamycin phosphate ranked first half of 2006 49 (2006 ranked 56), ranking first half of 2007 No. 89; gatifloxacin ranked first half of 2006 24-bit (2006 ranked 27), ranked first half of 2007 46. 4 major reshuffle top brand-name drugs from the sort of generic drugs, we can see that the changes do not seem to rank. However, due to fierce market competition, if the brand name of drugs,[link widoczny dla zalogowanych], the ranking changes are significant (see Table 4). Top 20 brand-name drugs in addition to the Yangtze River Pharmaceutical left grams (levofloxacin) always occupy the top spot in the seat, Novo Nordisk (Tianjin) Biotechnology Co., Ltd. Novolin 30R, Hangzhou MSD Pharmaceutical Co., Ltd. Thai energy, Beijing Tide Pharmaceutical Co., Ltd. and Guangzhou Baiyun Mountain Kaishi Pharmaceutical Factory of little change in pigment zenith, many species there are great changes. Sort forward varieties are: Bayer Baitang Ping (acarbose) from the first half of 2006 before the move to No. 5 in the first half of 2007 the first two; Hangzhou section 13 (2006 8-bit), first half of 2007 jumped to No. 3. It is worth noting, the Beijing Fourth Ring pharmaceutical Colin O (Cinepazide maleate injection) ranked first half of 2006, 23 (2006 ranking 17th),[link widoczny dla zalogowanych], ranked first half of 2007 6 . Friends of Mudanjiang City, Heilongjiang Shuxuetong Bo pharmaceutical injection, as a variety of traditional Chinese medicine in one fell swoop from the first half of 2006 jumped to 28 in the first half of 2007 the first eight. Bayer Pharmaceuticals in Germany thanks to complex music (moxifloxacin) is moved forward by 36 bits, from the first half of 2006 49-bit (No. 34 of 2006),[link widoczny dla zalogowanych], first half of 2007 jumped to 13th. Shanghai Biochemical Pharmaceutical Company an exclusive first promise of new health products (sodium tanshinone Ⅱ A) forward a ranking of 121, one stroke away from the 100 rose 16. It can be seen in the market of new products have amazing potential. The first half of 2006 No. 10 of the Yangtze River Pharmaceutical Group Co., Ltd. affiliated companies of the sea on the Haihai Ni Chao (gatifloxacin) fell to No. 124, No. 12 Rocephin, Roche Pharmaceuticals ( ceftriaxone) fell to No. 22, ranked 14th in the Jiangsu Hengrui pharmaceutical Oxaliplatin (oxaliplatin) fell to No. 25, ranked 15th in the Lunanxinkang Shandong Lunan Pharmaceutical Bate (isosorbide mononitrate) was reduced to 24-bit, Taiwan ranked 16th in the Pan-Pan-Health Health Shu Fu (ceftriaxone) fell to No. 31, Knoop Pharmaceutical (Jilin) ​​Co., Ltd. Kai Luoxin in 2006 ranked No. 2 in the first half, first half of 2007 is almost out of the market. In the top 20 brand-name drugs, joint ventures and foreign-invested enterprises and domestic brand-name drugs for half of each brand, Bayer occupy two seats, showing its strong position in hospital administration. Category from treatment point of view, the top 20 brand-name drugs,[link widoczny dla zalogowanych], there are seven antibiotics. Evident in the Chinese medicine hospital, although the total quantity of antibiotics under control, but still occupies an important position. Rank changes brand name drugs, in addition to the fierce market competition and marketing is the uneven number of factors, we must also take into account national policies and drug prices over bidding system is an important change factor, of course, state of Sino Philippine livelihood pharmacy clopidogrel (Plavix) from the first half of 2006, there are reasons of adverse drug reactions (eg, gatifloxacin) and so on. Table 4 brand name drugs 2O rankings before the 2007 Shanghai Medicine Vol 28 10 439